Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Tumor suppressor miR-145-5p sensitizes prolactinoma to bromocriptine by downregulating TPT1

28 Oct 2018

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Growth Hormone and Insulin-like Growth Factors
Share to MicroRNA in disease regulation
Share to Pituitary Gland Disorders and Treatments

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 30370446
DOI: 10.1007/s40618-018-0963-4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Tumor suppressor miR-145-5p sensitizes prolactinoma to bromocriptine by downregulating TPT1PMID 30370446Read ↗

Molecular pathogenesis of human prolactinomas identified by gene expression profiling, RT-qPCR, and proteomic analysesSemantic proximity Read ↗

microRNA expression profile and differentially-expressed genes in prolactinomas following bromocriptine treatmentSemantic proximity Read ↗

circOMA1-Mediated miR-145-5p Suppresses Tumor Growth of Nonfunctioning Pituitary Adenomas by Targeting TPT1Semantic proximity Read ↗

The Activation of p300 Enhances the Sensitivity of Pituitary Adenomas to Dopamine Agonist Treatment by Regulating the Transcription of DRD2Semantic proximity Read ↗

Lower PRDM2 expression is associated with dopamine-agonist resistance and tumor recurrence in prolactinomasSemantic proximity Read ↗

Curcumin Sensitizes Prolactinoma to Bromocriptine by Activating the ERK/EGR1 and Inhibiting AKT/GSK3β Signaling PathwaySemantic proximity Read ↗

Phosphorylation of Pit-1 by Cyclin-Dependent Kinase 5 at Serine 126 is Associated with Cell Proliferation and Poor Prognosis in ProlactinomasSemantic proximity Read ↗

Association of prolactin receptor (PRLR) variants with prolactinomasSemantic proximity Read ↗

Phosphorylation of Pit-1 by Cyclin-dependent Kinase 5 at Serine 126 is Associated With Cell Proliferation and Poor Prognosis in ProlactinomasSemantic proximity Read ↗

High-throughput screening for Cushing’s disease: therapeutic potential of thiostrepton via cell cycle regulationSemantic proximity Read ↗

Human prolactin and its antagonist, hPRL-G129R, regulate bax and bcl-2 gene expression in human breast cancer cells and transgenic miceSemantic proximity Read ↗

Cabergoline and prolactinomas: lack of association between DRD2 polymorphisms and response to treatment.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.